Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check2 days agoChange DetectedA notice appears above the ClinicalTrials.gov navigation announcing NIH website updates and a terminology transition. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the study page continues to show a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden error page. The error page blocks the display of the trial details and related content.SummaryDifference18%

- Check58 days agoChange DetectedRevision badge updated from v3.6.5 to v3.6.6, signaling a minor site update. The study content remains unchanged.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page shows a new revision tag (Revision: v3.6.5) added to the footer. A large set of metadata keywords and MeSH terms were removed from the study record.SummaryDifference17%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.